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Ben Berkhout1*, Andrew Lever2, Mark Wainberg3, Ariberto Fassati4, Persephone Borrow5 and Masahiro Fujii6Dr. Monsef Benkirane, from the Laboratoire de Virologie
Moléculaire in Montpellier, France, has been announced
as the recipient of the 2013 Retrovirology Prize. This bi-
annual prize covers all aspects of the Retrovirology field
and celebrates groundbreaking research from retrovi-
rologists aged between 45 and 60. Monsef is among the
brightest young “stars” in HIV-1 biology. At 45 years of
age, he is the youngest recipient of the Retrovirology
prize. This year the competition was particularly fierce
with 4 strong contenders.
Monsef received training in immunology at the Uni-
versity of Marseille, France, and came to the laboratory
of our former editor-in-chief Kuan-Teh Jeang at the
NIH in 1995, where he worked on HIV-1 transcription
and post transcriptional regulation. In 1998, Monsef
established his own laboratory at the Human Genetics
Institute in Montpellier, France. He published the first
paper showing that the transcriptional activity of Tat is
regulated by post-translational modifications such as
acetylation and ubiquitylation [1,2]. He also published a
pioneering study on the identification of the subunit
composition of the Positive Transcription Elongation
Factor, PTEFb.
He focused on understanding the molecular mecha-
nisms leading to the establishment and maintenance of
transcriptionally silent HIV provirus, an important area
of research for the design of virus eradication strategies
(Cure for AIDS) [3]. His team provided the first demon-
stration of the role of the histone methyltransferase
Suv39H1 in HIV-1 transcriptional silencing [4]. Addition-
ally, he unraveled an intricate crosstalk between HIV tran-
scription and the cellular RNAi machinery [5-7].* Correspondence: b.berkhout@amc.uva.nl
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has occupied the study of HIV-1 for over 2 decades:
why myeloid cell and quiescent CD4+ T cells are
refractory to HIV-1 replication. He and his team have
made ground breaking contributions in this field.
They identified SAMHD1, a protein encoded by an
Aicardi-Goutières Syndrome susceptibility gene, as the
HIV-1 restriction factor operating in dendritic cells,
macrophages and quiescent CD4+ T cells [8]. The
identification of the restriction factor operating in
these cells has been a very challenging and competi-
tive area of research that received quite some atten-
tion in our journal recently [9-11].
Dr. Benkirane’s honors in research recognition include
elected membership in EMBO and French Academy of
Science Award (both 2012), and he was recently elected
to the American Academy of Microbiology (2013). He
has published over 60 peer-reviewed manuscripts and
review articles, very often in top journals such as Cell
and Nature. He has been an Editor of Retrovirology
since 2004 and organized the first Frontiers of Retrovi-
rology meeting in Montpellier in 2009.
To mark the award, an editorial will be published
in BioMed Central's open access journal Retroviro-
logy. The Retrovirology Prize recipient is selected by
Retrovirology's Editors based on nominations submitted
by the journal's Editorial Board. The biennial prize for
HIV or non-HIV related research consists of a $3,000
check and a crystal trophy. He will receive the prize at
the upcoming third Frontiers of Retrovirology meeting in
Cambridge, UK (http://www.frontiers-of-retrovirology.
com).
Past winners include Professor Masao Matsuoka from
Japan (2011), Professor Mike Malim from the United
Kingdom (2010) and Professor Thierry Heidmann from
France (2009).al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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